Sleep disorders in Parkinson's disease.

Area of Science:

• Neurology
• Sleep Medicine
• Neurodegenerative Diseases

Background:

• Sleep disorders are highly prevalent in Parkinson's disease (PD), severely diminishing patients' quality of life.
• Common sleep disturbances include insomnia, excessive daytime sleepiness, restless legs syndrome (RLS), and REM-sleep behavior disorder (RBD).

Purpose of the Study:

• To review the common sleep disorders in Parkinson's disease patients.
• To discuss causative factors, diagnostic approaches, and management strategies for sleep disturbances in PD.
• To highlight REM-sleep behavior disorder (RBD) as a potential early biomarker for neurodegenerative diseases.

Main Methods:

• Literature review and synthesis of current knowledge on sleep disorders in PD.
• Discussion of etiological factors, including neurodegeneration, medications, and comorbidities.
• Recommendations for diagnostic screening using validated questionnaires (e.g., PSQI, MOS, ESS, ISCS, SSS) and clinical evaluation.
• Emphasis on the importance of sleep specialist referral when necessary.

Main Results:

• Sleep disorders significantly affect PD patients' quality of life.
• Neurodegenerative processes, antiparkinsonian drugs, and comorbidities contribute to sleep disturbances.
• Validated screening tools and detailed medical history are essential for diagnosis.
• Optimizing dopaminergic therapy and specific sleep disorder treatments are key management strategies.

Conclusions:

• Effective management of sleep disorders in Parkinson's disease involves optimizing PD treatment and addressing specific sleep issues.
• REM-sleep behavior disorder (RBD) holds significant potential as an early indicator of neurodegeneration, crucial for future research.
• Further research into biomarkers and neuroprotective therapies for neurodegenerative diseases, particularly PD, is warranted.